Santini FC - Search Results

1

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

Gelatti ACZ, Drilon A, Santini FC. Gelatti ACZ, et al. Among authors: santini fc. Lung Cancer. 2019 Nov;137:113-122. doi: 10.1016/j.lungcan.2019.09.017. Epub 2019 Sep 23. Lung Cancer. 2019. PMID: 31568888 Free PMC article. Review.

2

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.

Sabari JK, Santini F, Bergagnini I, Lai WV, Arbour KC, Drilon A. Sabari JK, et al. Curr Oncol Rep. 2017 Apr;19(4):24. doi: 10.1007/s11912-017-0587-4. Curr Oncol Rep. 2017. PMID: 28303491 Free PMC article. Review.

3

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers.

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A. Sabari JK, et al. Among authors: santini fc. Onco Targets Ther. 2017 Apr 6;10:1983-1992. doi: 10.2147/OTT.S109295. eCollection 2017. Onco Targets Ther. 2017. PMID: 28435288 Free PMC article. Review.

4

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Santini FC, Kunte S, Drilon A. Santini FC, et al. Transl Lung Cancer Res. 2017 Jun;6(3):393-395. doi: 10.21037/tlcr.2017.04.06. Transl Lung Cancer Res. 2017. PMID: 28713684 Free PMC article. No abstract available.

5

Atezolizumab for the treatment of non-small cell lung cancer.

Santini FC, Rudin CM. Santini FC, et al. Expert Rev Clin Pharmacol. 2017 Sep;10(9):935-945. doi: 10.1080/17512433.2017.1356717. Epub 2017 Jul 27. Expert Rev Clin Pharmacol. 2017. PMID: 28714780 Free PMC article. Review.

6

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Santini FC, Rizvi H, Plodkowski AJ, Ni A, Lacouture ME, Gambarin-Gelwan M, Wilkins O, Panora E, Halpenny DF, Long NM, Kris MG, Rudin CM, Chaft JE, Hellmann MD. Santini FC, et al. Cancer Immunol Res. 2018 Sep;6(9):1093-1099. doi: 10.1158/2326-6066.CIR-17-0755. Epub 2018 Jul 10. Cancer Immunol Res. 2018. PMID: 29991499 Free PMC article.

7

Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.

Chaft JE, Dagogo-Jack I, Santini FC, Eng J, Yeap BY, Izar B, Chin E, Jones DR, Kris MG, Shaw AT, Gainor JF. Chaft JE, et al. Among authors: santini fc. Lung Cancer. 2018 Aug;122:67-71. doi: 10.1016/j.lungcan.2018.05.020. Epub 2018 May 22. Lung Cancer. 2018. PMID: 30032847 Free PMC article.

8

TRK Inhibitors in Non-Small Cell Lung Cancer.

Harada G, Gongora ABL, da Costa CM, Santini FC. Harada G, et al. Among authors: santini fc. Curr Treat Options Oncol. 2020 Apr 23;21(5):39. doi: 10.1007/s11864-020-00741-z. Curr Treat Options Oncol. 2020. PMID: 32328803 Review.

9

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer.

Solomon BJ, Zhou CC, Drilon A, Park K, Wolf J, Elamin Y, Davis HM, Soldatenkova V, Sashegyi A, Lin AB, Lin BK, F Loong HH, Novello S, Arriola E, Pérol M, Goto K, Santini FC. Solomon BJ, et al. Among authors: santini fc. Future Oncol. 2021 Mar;17(7):763-773. doi: 10.2217/fon-2020-0935. Epub 2020 Nov 5. Future Oncol. 2021. PMID: 33150799 Free article.

10

NTRK fusions in lung cancer: From biology to therapy.

Harada G, Santini FC, Wilhelm C, Drilon A. Harada G, et al. Among authors: santini fc. Lung Cancer. 2021 Nov;161:108-113. doi: 10.1016/j.lungcan.2021.09.005. Epub 2021 Sep 16. Lung Cancer. 2021. PMID: 34563714 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters